Thelansis Publishes Multiple Sclerosis Market Outlook & Forecast: Navigating One Of Neurology's Most Rapidly Evolving Markets

Thelansis, a leading pharmaceutical intelligence and market research firm, has released its highly anticipated Multiple Sclerosis (MS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (2026-2036). Built for pharma and biotech decision-makers, the report delivers 10-year, patient-based market forecasts